[THE INVESTOR] Huons Global announced on Sept. 19 that it has acquired shares of its subsidiaries and affiliates, including Huons and Humedix, worth 8 billion won (US$7.13 million) to demonstrate its management accountability and earn shareholders’ trust.
Huons Global split off from pharmaceutical company Huons in May and is its holding company.
